Search

Search Results

• 

  Androgen deprivation therapy (castration therapy) and pedophilia: What’s new

  Mauro Silvani, Nicola Mondaini, Alessandro Zucchi

  222-226

  30-09-2015

  https://doi.org/10.4081/aiua.2015.3.222

  10500

  Downloads: 5513
• 

  Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

  Murat Bagcioglu, Cristian Surcel, Serkan Ozcan, Cristian Mirvald, Mehmet Ali Karagoz, Mert Ali Karadag, Emre Huri, Kemal Sarica

  282-286

  31-12-2017

  https://doi.org/10.4081/aiua.2017.4.282

  1297

  Downloads: 769

• Impact of statins on metastatic castration-resistant prostate cancer patients receiving new hormonal agents

  Ana Marta Ferreira, Tiago Sousa, Roberto Jarimba, Vasco Quaresma, Pedro Nunes, Edgar Tavares da Silva, Arnaldo Figueiredo

  03-11-2025

  https://doi.org/10.4081/aiua.2025.14179

  813

  Downloads: 491
• 

  Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study

  Roberto Saldanha Jarimba, Miguel Nobre Eliseu, João Pedroso Lima, Vasco Quaresma, Pedro Moreira, Pedro Coelho Nunes, Edgar Tavares da Silva, Arnaldo José Figueiredo

  393-398

  20-12-2021

  https://doi.org/10.4081/aiua.2021.4.393

  1873

  Downloads: 1145
• 

  Effects of testosterone replacement on lipid profile, hepatotoxicity, oxidative stress, and cognitive performance in castrated wistar rats

  Oumayma Boukari, Wahid Khemissi, Soumaya Ghodhbane, Aida Lahbib, Olfa Tebourbi, Khemais Ben Rhouma, Mohsen Sakly, Dorsaf Hallegue

  15-11-2023

  https://doi.org/10.4081/aiua.2023.11593

  1579

  Downloads: 751
• 

  Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis

  Gianpaolo Perletti, Elena Monti, Emanuela Marras, Anne Cleves, Vittorio Magri, Alberto Trinchieri, Paul S. Rennie

  121-129

  07-07-2015

  https://doi.org/10.4081/aiua.2015.2.121

  11128

  Downloads: 5955
• 

  Management of self-inflicted orchiectomy in psychiatric patient. Case report and non-systematic review of the literature

  Marco Garofalo, Alessandro Colella, Paolo Sadini, Lorenzo Bianchi, Giacomo Saraceni, Eugenio Brunocilla, Giorgio Gentile, Fulvio Colombo

  220-223

  30-09-2018

  https://doi.org/10.4081/aiua.2018.3.220

  2194

  Downloads: 1236
• 

  Prostate-specific antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

  Alexandre Mendonça Macedo, Rita Gameiro Marques, Margarida Cunha André, Nuno Silva Figueira, Miguel Leal Carvalho

  22-02-2023

  https://doi.org/10.4081/aiua.2023.11052

  1320

  Downloads: 1029
• 

  C reactive protein/Albumin ratio as predictor of prognosis in castration resistant metastatic prostate cancer

  João Lorigo, Edgar Tavares Silva, João Pedroso Lima, Vasco Quaresma, Rui Pedrosa, Arnaldo Figueiredo

  11-07-2023

  https://doi.org/10.4081/aiua.2023.11242

  1228

  Downloads: 648
• 

  Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC

  Viviana Frantellizzi, Julia Lazri, Mariano Pontico, Arianna Pani, Giuseppe De Vincentis

  01-10-2020

  https://doi.org/10.4081/aiua.2020.3.196

  1180

  Downloads: 828

• Relugolix in treatment of prostate cancer: a review

  Ioannis Kyriazis, Themistoklis Bellos, Stamatios Katsimperis, Panagiotis Angelopoulos, Panagiotis Neofytoy, Ioannis Varkarakis, Andreas Skolarikos, Athanasios Papatsoris

  13-11-2025

  https://doi.org/10.4081/aiua.2025.14277

  1020

  Downloads: 481
• 

  Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn

  Asmaa Ismail, Hazem Elmansy, Walid Shahrour, Owen Prowse, Ahmed Kotb

  265-266

  14-01-2020

  https://doi.org/10.4081/aiua.2019.4.265

  1356

  Downloads: 823

• Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer

  Ana Marta Ferreira, Roberto Jarimba, André Rego, João Gama, Rui Almeida, Miguel Eliseu, Vasco Quaresma, Pedro Nunes, Vitor Sousa, Arnaldo Figueiredo

  31-03-2026

  https://doi.org/10.4081/aiua.2026.14731

  199

  Downloads: 147
• 

  Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform

  Giuseppe Albino, Francesca Vendittelli, Carmela Paolillo, Cecilia Zuppi, Ettore Capoluongo

  164-169

  31-12-2013

  https://doi.org/10.4081/aiua.2013.4.164

  2343

  Downloads: 2158

• The role of immunotherapy in urological cancers

  Efe Bosnali, Enes Malik Akdas, Engin Telli, Kerem Teke, Onder Kara

  30-05-2024

  https://doi.org/10.4081/aiua.2024.12307

  2675

  Downloads: 1641
• 

  Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

  Gianpaolo Perletti

  74-75

  31-03-2016

  https://doi.org/10.4081/aiua.2016.1.74

  1769

  Downloads: 1218

• BRCA mutations and prostate cancer: should urologist improve daily clinical practice?

  Simona Vatrano, Pietro Pepe, Ludovica Pepe, Nuccia Vella, Cristina Alario, Alessia Chiarandà, Chiara Taranto, Renato Scillieri, Cristina Mauceri, Filippo Fraggetta

  17-04-2025

  https://doi.org/10.4081/aiua.2025.13635

  1686

  Downloads: 674
• 

  Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

  Johann de Bono, Liji Shen, Oliver Sartor

  72-73

  31-03-2016

  https://doi.org/10.4081/aiua.2016.1.72

  2611

  Downloads: 1304